Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68084-698

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68084-698). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ahp69801

Venlafaxine Hydrochloride 75 mg extended-release capsule, showing a two-tone capsule with one half gray and the other half white. The gray half is imprinted with the letter 'E' and the white half with the number '73' in black. The capsule is shown against a background with a millimeter scale for size reference.*

FDA Label Image

Ahp70901

Venlafaxine Hydrochloride extended release oral capsule imprinted with the code 'E 74'. The capsule is opaque, white in color, and capsule-shaped with no other markings visible. The image shows both sides of the capsule against a measurement grid background.*

FDA Label Image

Ahp71301

Venlafaxine Hydrochloride 75 mg extended-release oral capsules, red in color, imprinted with 'E 89' on one side. Image shows two capsules with one side displaying the imprint and the other side plain red. Labeler is American Health Packaging.*

FDA Label Image

Structural Formula (Structure)

Chemical structure of venlafaxine hydrochloride showing its molecular composition and bonding arrangement. The diagram includes the characteristic cyclohexanol ring and methoxy-substituted phenyl group, labeled with relevant atomic groups and bonds.*

FDA Label Image

Figure 1: Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv) In Special Populations (Figure1)

A pharmacokinetic chart showing fold changes and 90% confidence intervals for venlafaxine and its O-desmethylvenlafaxine metabolite (ODV) under various special population conditions including hepatic impairment, renal impairment, CYP2D6 poor/extensive metabolizer status, age over 60 years, and gender differences. The x-axis represents change relative to the reference value, and the y-axis lists the special populations and analytes.*

FDA Label Image

Figure 2: Effect Of Other Drugs On The Pharmacokinetics Of Venlafaxine And Active Metabolite O-desmethylvenlafaxine (odv) (Figure2)

A dot plot chart showing the fold change and 90% confidence intervals for the pharmacokinetic parameters Cmax and AUC of venlafaxine after interaction with various drugs including Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium. The X-axis represents the change relative to the reference value, ranging from 0 to 3, while the left side lists interacting drugs and analytes.*

FDA Label Image

Figure 3: Effect Of Venlafaxine On The Pharmacokinetics Of Interacting Drugs And Their Active Metabolites (Figure3)

A chart depicting the pharmacokinetic interactions of various drugs with parameters including Cmax and AUC fold changes relative to a reference value. The x-axis shows fold change ranging from 0 to 3, while the y-axis lists interacting drugs like ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium, along with their analytes and pharmacokinetic measures.*

FDA Label Image

37.5 mg Venlafaxine HCl Extended-release Capsules Carton.jpg (37.5 mg Venlafaxine HCl Extended Release Capsules Carton.jpg)

Label for Venlafaxine Hydrochloride Extended-Release Capsules USP, 37.5 mg strength. The label indicates a package containing 100 capsules (10 x 10) for oral use, distributed by American Health Packaging. It includes storage instructions, a pharmacist notice to dispense with a medication guide, and a QR code for current medication guide and prescribing information. The NDC is 68084-698-01.*

FDA Label Image

37.5 mg Venlafaxine HCl Extended-release Capsule Blister.jpg (37.5 mg Venlafaxine HCl Extended Release Capsule Blister 01.jpg)

Label for Venlafaxine Hydrochloride Extended-Release Capsule 37.5 mg by American Health Packaging. The label includes the product name, dosage strength, barcode, National Drug Code (NDC), and space for expiration date and lot number. The label is repeated multiple times on the sheet.*

FDA Label Image

75 mg Venlafaxine HCl Extended-release Capsules Carton.jpg (75 mg Venlafaxine HCl Extended Release Capsules Carton 01)

Label for Venlafaxine Hydrochloride Extended-Release Capsules USP 75 mg, contains 100 capsules (10 x 10), labeled for prescription use only. The label includes NDC 68084-709-01, instructions to dispense with a medication guide, storage conditions, and a QR code for medication guide and prescribing information. Distributed by American Health Packaging.*

FDA Label Image

75 mg Venlafaxine HCl Extended-release Capsule Blister.jpg (75 mg Venlafaxine HCl Extended Release Capsule Blister 01)

Multiple identical labels for Venlafaxine Hydrochloride Extended-Release 75 mg capsules. Each label includes the product name, strength, dosage form, a barcode, expiration date placeholder, lot number placeholder, and the labeler American Health Packaging, Columbus, Ohio.*

FDA Label Image

150 mg Venlafaxine HCl Extended-release Capsules Carton.jpg (150 mg Venlafaxine HCl Extended Release Capsules Carton 01)

Label for Venlafaxine Hydrochloride Extended-Release Capsules USP 150 mg, containing 100 capsules (10 x 10) in an oral extended-release capsule dosage form. The label shows the National Drug Code (NDC) 68084-713-01 and notes that the product is Rx only. Additional label text includes pharmacist instructions, storage conditions, and distributor information for American Health Packaging.*

FDA Label Image

150 mg Venlafaxine HCl Extended-release Capsule Blister.jpg (150 mg Venlafaxine HCl Extended Release Capsule Blister 01)

Multiple barcode labels for Venlafaxine Hydrochloride Extended-Release Capsules USP 150 mg by American Health Packaging. Each label includes the drug name, strength, dosage form, labeler name and location, a barcode, placeholder text for expiry date and lot number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.